How effective is Pulmicort Respules for Copd (Chronic obstructive pulmonary disease) ?


Summary

5 Pulmicort respules users have rated its effectiveness for Copd.

Overall ratings: 2.4/5
Long term ratings: 2.5/5

This is a reivew of how effective Pulmicort respules (budesonide) is for Copd and for what kind of people. The study is created by eHealthMe and is updated continuously.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Jun, 26, 2017

5 people are studied for taking Pulmicort respules in Copd


Overall effectiveness (number of people)

Does Pulmicort respules work for your Copd (overall)?

Long term effectiveness (number of people)

Does Pulmicort respules work for your Copd (long term)?

Pulmicort respules effectiveness for Copd (number of people)

Overall:
  • not at all: 0
  • somewhat: 3
  • moderate: 2
  • high: 0
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 1
  • moderate: 1
  • high: 0
  • very high: 0

Gender of people who take Pulmicort respules for Copd *

  • female: 80 %
  • male: 20 %

Age of people who take Pulmicort respules for Copd *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 20 %
  • 50-59: 20 %
  • 60+: 60 %

Who finds Pulmicort Respules more effective for Copd?


* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

Pulmicort Respules

Pulmicort respules has active ingredients of budesonide. It is often used in asthma. (latest outcomes from Pulmicort respules 1,843 users)

Copd

Copd (chronic obstructive pulmonary disease) has been reported by people with chronic obstructive pulmonary disease, osteoporosis, high blood pressure, rheumatoid arthritis, pain (latest reports from 107,884 Copd patients).

Related studies: